Long-acting injectable antipsychotics. Review and recent developments
Zolezzi, M.
Neurosciences 10(2): 126-131
2005
ISSN/ISBN: 1319-6138 PMID: 22473224 Document Number: 588640
Long-acting injectable antipsychotics, also known as `depots`, were developed in the late 1960s as an attempt to improve compliance and long-term management of schizophrenia. Despite their availability for over 30 years, guidelines for their use and data on patients for whom long-acting injectable antipsychotics are most indicated are sparse and vary considerably. A review of the perceived advantages and disadvantages of using long-acting injectable antipsychotics is provided in this article, as well as a review of the literature to update clinicians on the current advances of this therapeutic option to optimize compliance and long-term management of chronic schizophrenia.